.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Accenture
US Army
Federal Trade Commission
Teva
McKesson
Novartis
Cerilliant
Citi

Generated: November 24, 2017

DrugPatentWatch Database Preview

Dextroamphetamine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dextroamphetamine sulfate and what is the scope of dextroamphetamine sulfate patent protection?

Dextroamphetamine sulfate
is the generic ingredient in five branded drugs marketed by Actavis Elizabeth, Ferndale Labs, Glaxosmithkline, Lannett, Nesher Pharms, Able, Mast Mm, Purepac Pharm, Halsey, Novel Labs Inc, Mikart, Mylan Pharms Inc, Teva, Mallinckrodt, Mayne Pharma, Tris Pharma Inc, Avanthi Inc, Shire, Epic Pharma Llc, Barr, Idt Australia Ltd, Sandoz, Outlook Pharms, Impax Labs Inc, Vitarine, Aurolife Pharma Llc, and Vintage Pharms Llc, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for dextroamphetamine sulfate. Twenty-six suppliers are listed for this compound.

Summary for dextroamphetamine sulfate

Pharmacology for dextroamphetamine sulfate

Medical Subject Heading (MeSH) Categories for dextroamphetamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL040365-001Oct 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Mikart
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL090533-006Oct 25, 2011RXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL206735-003Jan 27, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL076137-002Jan 18, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL040367-001Oct 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Shire
DEXTROSTAT
dextroamphetamine sulfate
TABLET;ORAL084051-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL083903-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
DEXEDRINE
dextroamphetamine sulfate
TABLET;ORAL084935-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL209111-003Jun 27, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Able
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL076814-001Aug 25, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Medtronic
Chinese Patent Office
Chubb
Boehringer Ingelheim
AstraZeneca
Dow
Colorcon
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot